Expertise
Cyanide has long been known for its extreme toxicity and is of concern as an environmental hazard. Our laboratory has recently discovered that cyanide is produced in brain tissue. Rat brain concentration is estimated to be 7 micromolar. Treatment with morphine doubles brain cyanide 15 min after ip administration. Pretreatment with the morphine antagonist, naloxone abolishes the response. Similar results are obtained in a cultured neuronal model (rat pheochromocytoma, PC12 cells). Cyanide levels for hypothalamus and hippocampus are above that for cerebral cortex. Cyanide generation may be more active in certain brain areas. Studies on the mechanism of cyanide generation reveal that an oxidative process is involved similar to that proposed for cyanide production in white blood cells. A blocker of myeloperoxidase inhibits cyanide generation and lowers cyanide concentrations in rat brain to undetectable levels. This inhibitor also blocks the increase in brain cyanide caused by morphine. Furthermore, glycine, which enhances cyanide production in white blood cells, also increases cyanide generation in PC12 cells. It appears that an oxidative process involving myeloperoxidase and glycine results in cyanide production in neuronal tissue as well as in white blood cells. Cyanide can enhance neurotransmitter release and may function as a gaseous neuromodulator similar to nitric oxide. However the physiological and pathological significance of brain cyanide remains to be defined. Our "Neurotox Lab" has also studied trimethyltin (TMT), a chemical used in the manufacture of plastics and silicon rubber. This substance is extremely neurotoxic and causes a complex syndrome including delerium, memory defects, stuttering, epileptic seizures and depression. The neurons involved in memory are especially sensitive and humans exposed to TMT show marked learning impairment, which greatly affects their lives. Using cultured brain cells and appropriate blocking agents, we have shown that TMT kills neurons by at least two mechanisms, one involving oxidative stress and the other a non-oxidative process. We also showed that when brain neurons are cultured with astrocytes, TMT-induced damage is attenuated, possibly by an antioxidant action of astrocytes. Further work needs to be done to clarify TMT's neurotoxic mechanisms.
Past Affiliations

Professor, Department of Pharmacology and Toxicology, Indiana University-Purdue University Indianapolis, School of Medicine (past)

Professor Emeritus, Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University (past)

Professor, Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University (past)

Professor, Medicinal Chem & Molecular Pharmacology, College of Pharmacy, Nursing and Health Sciences (past)

Degrees
PhD, Northwestern University, 1959
MS, Purdue University, 1957
BS, Ohio State University, 1955
Keywords
drugs or drug abuse diabetes diabetic retinopathy metabolic diseases neurological disorders neuromuscular disorders dementia arteriosclerosis or atherosclerosis neurotransmitters neuropharmacology membrane structure or function